Skip to main content
    R

    Revelation Biosciences Inc (REVB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.90
    +0.08 (+2.09%)

    Market Cap: $2.43M

    Last updated: Nov 17, 2026 at 4:25 PM ET

    Revelation Biosciences Inc (REVB) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Revelation Biosciences (REVB) has a latest price of $3.90 on Nov 17, 2026, 43.7% below its 52-week high of $6.93. Its price fell 84.5% over the past 12 months. The month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 95.1%.

    Price Chart

    From Nov 2020 to Oct 2026, its highest month-end close was $14,461,922.51 in Feb 2021 and its lowest $4.03 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart REVB with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for REVB.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 49.8%, and over 6 months it fell 45.9%. The month-end price fell 100.0% over the 3 years through Oct 2026, a compound annual decline of 94.5%.

    PeriodChange
    1 month+18.7%
    3 months-49.8%
    6 months-45.9%
    12 months-84.5%
    12 months, with dividends-84.5%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-100.0%-94.5%
    5 years-100.0%-95.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2021, when the price rose 1.5%, and its weakest was 2022, when it fell 98.1%.

    YearCloseChange
    2026 through Oct 2026$4.03-82.0%
    2025$22.39-96.4%
    2024$619.46-96.9%
    2023$20,204.39-92.5%
    2022$268,215.75-98.1%
    2021$14,391,376.55+1.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 22.5% below its 50-day average of $5.03 and 46.3% below its 200-day average of $7.26.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$3.90
    52-week high$6.93-43.7%
    52-week low$0.47+735.1%
    50-day average$5.03-22.5%
    200-day average$7.26-46.3%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 100.0%.

    MeasureValue
    1-year beta1.70
    Largest fall, 1 year-89.8%
    Largest fall, 3 years-100.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About REVB

    What is REVB's 1-year price change?

    Revelation Biosciences's price fell 84.5% over the past 12 months. With dividends included, the 12-month total return was -84.5%.

    What is REVB's 5-year price change?

    Revelation Biosciences's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 95.1%. These figures leave out dividends.

    What is REVB's 52-week high and low?

    Revelation Biosciences's 52-week high is $6.93 and its 52-week low is $0.47. Its latest price of $3.90 on Nov 17, 2026 is 43.7% below the high.

    What is REVB's beta?

    Revelation Biosciences's 1-year beta against the S&P 500 is 1.70, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 89.8%.

    Is the REVB chart free?

    Yes. Advanced Charting for REVB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.